Possibilities of influencing cardiovascular risk in type 2 diabetes mellitus by antidiabetic treatment Lowering of cardiovascular risk in treatment with liraglutide - Results of the LEADER
Vnitřní lékar̆stvĭ, 2016, Vol.62 (7-8), p.613 [Peer Reviewed Journal]ISSN: 0042-773X ;PMID: 27627086
Digital Resources/Online E-Resources